| __timestamp | Amneal Pharmaceuticals, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 2026300000 |
| Thursday, January 1, 2015 | 109679000 | 2682700000 |
| Friday, January 1, 2016 | 118757000 | 2810000000 |
| Sunday, January 1, 2017 | 109046000 | 2582000000 |
| Monday, January 1, 2018 | 230435000 | 2473000000 |
| Tuesday, January 1, 2019 | 289598000 | 2554000000 |
| Wednesday, January 1, 2020 | 326727000 | 2367000000 |
| Friday, January 1, 2021 | 365504000 | 2624000000 |
| Saturday, January 1, 2022 | 399700000 | 2625000000 |
| Sunday, January 1, 2023 | 429675000 | 2917000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding operational costs is crucial. From 2014 to 2023, Amneal Pharmaceuticals, Inc. and Bausch Health Companies Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. Amneal's SG&A costs have surged by over 400%, starting from a modest 8% of Bausch's expenses in 2014 to nearly 15% in 2023. Meanwhile, Bausch Health, despite fluctuations, maintained a relatively stable SG&A expenditure, peaking in 2015. This comparison highlights Amneal's aggressive expansion strategy, while Bausch's consistent spending reflects a more stable operational approach. As the pharmaceutical landscape continues to shift, these trends offer valuable insights into each company's strategic priorities and financial health.
SG&A Efficiency Analysis: Comparing Novartis AG and Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Bausch Health Companies Inc.
Blueprint Medicines Corporation or Amneal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Revenue Showdown: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Bausch Health Companies Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Bausch Health Companies Inc. and BioCryst Pharmaceuticals, Inc.